Hyomin Kim
Gerontology · Bell Gardens, CANPI 1295188464
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 281 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,181 and has fallen 60.7% since, to $856 in 2025. Among gerontology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 281 payments — averaging $22.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$846
- Johnson & Johnson$709
- Boehringer Ingelheim$611
- Novo Nordisk$421
- Lilly USA, LLC$410
- plus $2K from 20 others
What the payments were for
- Food & beverage$6,209100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 46 | $1,005 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 59 | $846 |
| Johnson & Johnson | 25 | $709 |
| Boehringer Ingelheim | 22 | $611 |
| Novo Nordisk | 19 | $421 |
| Lilly USA, LLC | 15 | $410 |
| Bayer | 11 | $278 |
| Optinose US, Inc. | 10 | $245 |
| Merck | 10 | $196 |
| AbbVie | 8 | $195 |
| Xeris Pharmaceuticals, Inc. | 8 | $182 |
| Sanofi-aventis U.S. LLC | 8 | $172 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $168 |
| Radius Health, Inc. | 6 | $151 |
| AstraZeneca | 6 | $140 |
| Astellas Pharma US Inc | 3 | $87 |
| Amarin Pharma, Inc. | 3 | $69 |
| Ironwood Pharmaceuticals, Inc | 3 | $68 |
| Dexcom, Inc. | 3 | $67 |
| Phathom Pharmaceuticals, Inc. | 2 | $61 |
| Sumitomo Pharma America, Inc. | 1 | $37 |
| Ardelyx, Inc. | 1 | $28 |
| Kowa Pharmaceuticals America, Inc. | 1 | $22 |
| Smith+Nephew | 1 | $17 |
| Abbott | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
How this compares
$6,215 in reported general payments places this provider in the 90th percentile of 348 gerontology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 61 | $43,865 |
| JanuviaSitagliptin Phosphate | 34 | $30,015 |
| TradjentaLinagliptin | 43 | $28,678 |
| OzempicSemaglutide | 24 | $27,202 |
| FarxigaDapagliflozin Propanediol | 18 | $17,930 |
| EntrestoSacubitril/Valsartan | 12 | $15,746 |
| Colchicine | 19 | $1,183 |
| Atorvastatin Calcium | 85 | $781 |
| Metformin Hcl | 72 | $636 |
| Levothyroxine Sodium | 36 | $561 |
| Lisinopril | 55 | $425 |
| Amlodipine Besylate | 113 | $421 |
| Alendronate Sodium | 34 | $394 |
| Losartan Potassium | 48 | $390 |
| Metoprolol Succinate | 18 | $311 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $611 | $72,543104 claims |
| MerckJanuvia | $196 | $30,01534 claims |
| Novo NordiskOzempic | $421 | $27,20224 claims |
| AstraZenecaFarxiga | $140 | $17,93018 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 348 gerontology providers in California.
Other gerontology in Bell Gardens
- Lovely IsraelSanta Monica$95K
- Leslie TarlowLos Angeles$58K
- Christine PartamianPorter Ranch$41K
- Elsa Pineda-FloresLos Angeles$24K
- Maria MottaDuarte$23K
- Daniel ChiuOrange$17K
- Katiaryna KulinichChula Vista$15K
- Nataliya OsorioRiverside$13K
- Anne Marie de Joya ReeveDuarte$11K
- Wendy AlmonteLemoore$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.